| scholarly article | Q13442814 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| glycated hemoglobin | Q311213 | ||
| P304 | page(s) | 2267-2271 | |
| P577 | publication date | 1987-12-01 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group | |
| P478 | volume | 33 |
| Q37022761 | Aortic distensibility in type 1 diabetes |
| Q88167231 | Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D |
| Q47423928 | Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes |
| Q36503844 | Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes |
| Q89239963 | Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts |
| Q37022573 | Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects |
| Q37054973 | Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study |
| Q36001688 | Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes |
| Q31036580 | Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) |
| Q37333543 | Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions |
| Q46862199 | Diet and diabetic retinopathy: insights from the Diabetes Control and Complications Trial (DCCT). |
| Q37181434 | Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement and Coaching for Health (PEACH) pragmatic cluster randomised controlled trial |
| Q37193344 | Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC. |
| Q45260940 | Evaluation of turbidimetric inhibition immunoassay (TINIA) and HPLC methods for glycated haemoglobin determination. |
| Q72401478 | Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance |
| Q33935606 | Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma |
| Q51372848 | Glycated hemoglobin, diabetes mellitus, and cardiovascular risk in a cross-sectional study among She Chinese population. |
| Q37054987 | Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat |
| Q30426632 | Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus |
| Q40615889 | Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). |
| Q37110516 | Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study |
| Q37082040 | Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study |
| Q35976427 | High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes |
| Q36318280 | High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes |
| Q28360409 | Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial |
| Q45009681 | Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. |
| Q22250887 | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes |
| Q37239783 | Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus |
| Q34527165 | Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes |
| Q37391378 | Long-Term Performance of Point-of-Care Hemoglobin A1c Assays |
| Q35769521 | Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort |
| Q33793824 | Musculoskeletal complications in type 1 diabetes |
| Q35548457 | Myocardial structure, function, and scar in patients with type 1 diabetes mellitus |
| Q39169641 | National continuous surveys on internal quality control for HbA1c in 306 clinical laboratories of China from 2012 to 2016: Continual improvement. |
| Q36775168 | Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes |
| Q37584378 | Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes |
| Q34542912 | Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes |
| Q33281823 | Patient Engagement and Coaching for Health: The PEACH study--a cluster randomised controlled trial using the telephone to coach people with type 2 diabetes to engage with their GPs to improve diabetes care: a study protocol |
| Q34053743 | Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study |
| Q34436575 | Prevalence of hemoglobin variants in a diabetic population at high risk of hemoglobinopathies and optimization of HbA1c monitoring by incorporating HPLC in the laboratory workup |
| Q34527201 | Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study |
| Q36369405 | Relation between carotid intima-media thickness and left ventricular mass in type 1 diabetes mellitus (from the Epidemiology of Diabetes Interventions and Complications [EDIC] Study) |
| Q37076749 | Relationship of Family History of Type 2 Diabetes, Hypoglycemia, and Autoantibodies to Weight Gain and Lipids With Intensive and Conventional Therapy in the Diabetes Control and Complications Trial |
| Q30837772 | Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy |
| Q36820764 | Risk Factors for Cardiovascular Disease in Type 1 Diabetes |
| Q63869350 | Risk Factors for Kidney Disease in Type 1 Diabetes |
| Q92126756 | Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study |
| Q37404357 | Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. |
| Q36086134 | Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study |
| Q33822518 | Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S |
| Q41389392 | Socioeconomic Status, Waist-to-Hip Ratio, and Short-Term Heart Rate Variability in Cambodians with Type 2 Diabetes |
| Q34627590 | The "cost" of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice |
| Q30477859 | The Diabetes Manual trial protocol - a cluster randomized controlled trial of a self-management intervention for type 2 diabetes [ISRCTN06315411] |
| Q35591658 | The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes |
| Q42349649 | Translating the A1C Assay |
Search more.